1. Arvin, A. M. 2000. Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol. Blood Marrow Transplant.6:219-230.
2. Arvin, A. M. 2001. Varicella-zoster virus, p. 2731-2767. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven Publishers, Philadelphia, Pa.
3. Centers for Disease Control and Prevention. 2004. CDC guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Morbid. Mortal. Wkly. Rep.49:RR-10.
4. Han, C. S., W. Miller, R. Haake, and D. Weisdorf. 1994. Varicella-zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant.13:277-283.
5. Kalter, Z. G., S. Steinberg, and A. A. Gershon. 1997. Immune adherence hemagglutination: further observations on demonstration of antibody to varicella-zoster virus. J. Infect. Dis.135:1010-1013.